Regulatory updateRetina
Faricimab: start with the current EU product information
The EMA Vabysmo record is the authoritative entry point for EU product information, assessment documents and authorised indications.
European Medicines Agency ↗2 results
The EMA Vabysmo record is the authoritative entry point for EU product information, assessment documents and authorised indications.
European Medicines Agency ↗From 28 May 2026, mandatory use applies to actor registration, UDI/device registration, notified bodies and certificates, and market surveillance.
European Commission ↗